Carolina Conceptions is excited to share that we are currently enrolling eligible patients in a national Phase III clinical study designed to test a new medication used during IVF treatment. This study is part of the GRACE trial, led by Granata Bio, with our own Dr. John Park as the Principal Investigator.
What Is This IVF Study About?
The GRACE Study is designed to assess the safety and effectiveness of a new human menopausal gonadotropin (hMG) formulation. This medication may one day provide patients with an additional, cost-effective option during IVF treatment.
Compensation & Study Benefits
Eligible participants will receive all study-related treatment at no cost, including:
Up to two ovarian stimulation (COS) cycles
PGT-A
Up to three frozen embryo transfer (FET) cycles
All study medications included
Who Can Join?
If you are a woman between the ages of 18 and 42 who has been diagnosed with
infertility (difficulty becoming pregnant), with regular menstrual cycles (every 21-35
days), you may be eligible for participation in this study!
Due to the technical requirements of collecting samples for research, participants will need to be able to attend their monitoring visits at our Central Raleigh location that hosts our IVF Lab.
Interested in Participating?
If you’d like to learn more or be considered for enrollment, please book a consultation or appointment to meet with a physician. We will review your history, discuss your treatment goals, and determine whether the study may be a good fit for you.
Your participation helps advance the future of fertility care, and we are deeply grateful to every patient who considers joining.